分子診斷的全球市場:季報數據串流(2024年)

本報告考察了全球分子診斷市場，總結了有關市場規模和成長的最新信息，以及世界主要貨幣的波動如何影響每個市場的實際成長率。

目錄

每季的市場預測

• 分子感染疾病(呼吸系統，肝炎，HIV，HAI/敗血症，STI，結核，其他的感染疾病)
• 分子腫瘤學(包含CDx及分子組織學的分子化驗)
• 分子遺傳學的檢驗(遺傳性疾病和NIPT)
• 分子移植
• 分子NAT血庫檢驗
• 分子POC檢驗
• 分子COVID檢驗

NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports.

The most up-to-date information for company-wide success.

Buyers will receive data updates after each financial quarter for one year (for a total of four updates ). These comprehensive updates come in an Excel spreadsheet report easily usable by your marketing, business development, product management teams, and company executives.

With this data on hand your company will always have the most up-to-date information on the size and growth of the molecular diagnostics market. Also included in each update is how fluctuations in major global currencies have affected real growth for each of the markets examined. Corporate leadership teams can use the Datastream as a guide to help determine quarterly market share, and to measure your company's growth against the industry as a whole.

Quarterly Market estimates include:

• Molecular Infectious Disease (Respiratory, Hepatitis, HIV, HAIs/Sepsis, STI, TB and Other Infections)
• Molecular Oncology (Molecular Assays including CDx and Molecular Histology)
• Molecular Genetic Testing (Inherited Diseases and NIPT)
• Molecular Transplantation
• Molecular NAT Blood Banking Tests
• Molecular Molecular Point of Care Tests
• Molecular COVID Testing